Thyroid cancer is the most common endocrine malignancy, accounting for an estimated 22,000 new cases in the United States in 2003 alone.1 Papillary carcinoma is the most common subtype of the well-differentiated thyroid carcinomas (WTC). It has a relative frequency ranging from 75% to 85% among all thyroid cancers, and frequently follows an indolent course, with overall 10-year survival rates reported at 90% to 98%.2–4 Treatment of WTC consists of total or subtotal thyroidectomy, with resection of suspicious lymph nodes in the central compartment. Modified neck dissection is the accepted treatment of patients with lymph node metastasis to the lateral compartments of the neck. Patients with only central compartment lymph node metastasis usually undergo central compartment node dissection only. The overall recurrence and mortality rates for WTC have been reported at 20.5% and 8.4%, respectively, at a mean follow-up of 11.3 years.5 Patients with thyroid cancer are routinely monitored for recurrence by ultrasound examination of the central and lateral compartments of the neck, along with serum thyroglobulin testing. When thyroid cancer recurs, it is typically found within the surgical bed or in lymph nodes of the central or lateral compartments.4 Factors that have been associated with recurrence include young age at diagnosis, large size of the primary tumor, extracapsular spread, and a known distant metastasis.6 The 2 most common sites for distant metastasis of papillary carcinoma of the thyroid are to the lungs and bone.2 Cases of distant metastatic spread have been reported to occur from 5 to 47 years after initial treatment.7,8 Reported 10-year survival rates for patients with lung and bone metastases are 53% and 15%, respectively.9–11 Following diagnosis of distant metastases, overall mortality rates at 5 and 10 years are 65% and 75%, respectively.12 Recurrence in the central compartment can be either in lymph nodes or in the thyroid bed. A recurrence in the thyroid bed results in increased rates of morbidity and mortality.13 Recurrence in the lateral compartment usually occurs as lymph node metastasis. Surgery is recommended for recurrence in the central or lateral compartments of the neck that can be identified by ultrasonography (US). Reoperative surgery in the central or lateral compartments of the neck in patients who have undergone a previous neck dissection is difficult, however, due to distortion of normal tissue planes by scar tissue formation within the surgical bed, and such operations are subsequently associated with a higher rate of complications.9 Percutaneous radiofrequency ablation (RFA) and percutaneous ethanol (EtOH) injection are relatively new, minimally-invasive techniques that have been widely used as alternatives to surgical treatment in patients with hepatocellular carcinoma or liver metastasis from other malignancies.14 RFA has also shown promise as an effective treatment of metastatic malignancies in bone, lung, and kidney.15–22 RFA and EtOH injection with local anesthesia have recently been reported as alternatives to surgery in patients with local recurrence of WTC.4,15,23,24 In this study, we present our experience with treatment of local WTC recurrence by RFA or EtOH at long-term follow-up. We also report our initial experience using RFA to treat focal distant metastases of WTC.